TATA Health International Holdings Ltd. (HK:1255)
:1255
Total Valuation
TATA Health International Holdings Ltd. has a market cap or net worth of HK$376.41M. The enterprise value is HK$384.36M.
Market CapHK$376.41M
Enterprise ValueHK$384.36M
Share Statistics
TATA Health International Holdings Ltd. has 242,845,000 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding242,845,000
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
TATA Health International Holdings Ltd.’s return on equity (ROE) is -18.76 and return on invested capital (ROIC) is -86.14%.
Return on Equity (ROE)-18.76
Return on Assets (ROA)-0.18
Return on Invested Capital (ROIC)-86.14%
Return on Capital Employed (ROCE)54.66
Revenue Per Employee1.73M
Profits Per Employee-269.12K
Employee Count120
Asset Turnover1.14
Inventory Turnover4.26
Valuation Ratios
The current PE Ratio of TATA Health International Holdings Ltd. is ―. TATA Health International Holdings Ltd.’s PEG ratio is -0.00924.
PE Ratio―
PS Ratio0.59
PB Ratio-1.13
Price to Fair Value44.45
Price to FCF0.00
Price to Operating Cash Flow0.00
PEG Ratio-0.00924
Income Statement
In the last 12 months, TATA Health International Holdings Ltd. had revenue of 207.54M and earned -32.29M in profits. Earnings per share was -0.13.
Revenue207.54M
Gross Profit150.76M
Operating Income-34.38M
Pretax Income-35.42M
Net Income-32.29M
EBITDA-33.27M
Earnings Per Share (EPS)-0.13
Cash Flow
In the last 12 months, operating cash flow was 0.00 and capital expenditures 0.00, giving a free cash flow of 0.00 billion.
Operating Cash Flow0.00
Free Cash Flow0.00
Free Cash Flow per Share0.00
Dividends & Yields
TATA Health International Holdings Ltd. pays an annual dividend of HK$0.023, resulting in a dividend yield of ―
Dividend Per ShareHK$0.023
Dividend Yield―
Payout Ratio―
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.20
52-Week Price Change416.67%
50-Day Moving Average1.53
200-Day Moving Average0.84
Relative Strength Index (RSI)55.78
Average Volume (3m)0.00
Important Dates
TATA Health International Holdings Ltd. upcoming earnings date is Sep 2, 2026, TBA (Confirmed).
Last Earnings DateMar 31, 2026
Next Earnings DateSep 2, 2026
Ex-Dividend Date―
Financial Position
TATA Health International Holdings Ltd. as a current ratio of 0.75, with Debt / Equity ratio of -47.52%
Current Ratio0.75
Quick Ratio0.68
Debt to Market Cap0.34
Net Debt to EBITDA-0.43
Interest Coverage Ratio-19.94
Taxes
In the past 12 months, TATA Health International Holdings Ltd. has paid 626.00K in taxes.
Income Tax626.00K
Effective Tax Rate-0.02
Enterprise Valuation
TATA Health International Holdings Ltd. EV to EBITDA ratio is -2.73, with an EV/FCF ratio of 0.00.
EV to Sales0.44
EV to EBITDA-2.73
EV to Free Cash Flow0.00
EV to Operating Cash Flow0.00
Balance Sheet
TATA Health International Holdings Ltd. has HK$22.40M in cash and marketable securities with HK$35.54M in debt, giving a net cash position of -HK$13.15M billion.
Cash & Marketable SecuritiesHK$22.40M
Total DebtHK$35.54M
Net Cash-HK$13.15M
Net Cash Per Share-HK$0.05
Tangible Book Value Per Share-HK$0.07
Margins
Gross margin is 80.43%, with operating margin of -16.56%, and net profit margin of -15.56%.
Gross Margin80.43%
Operating Margin-16.56%
Pretax Margin-17.07%
Net Profit Margin-15.56%
EBITDA Margin-16.03%
EBIT Margin-16.56%
Analyst Forecast
The average price target for TATA Health International Holdings Ltd. is ―, which is 11.43% higher than the current price. The consensus rating is ―
Price Target―
Price Target Upside―
Analyst Consensus―
Analyst Count0
Revenue Growth Forecast―
EPS Growth Forecast―